A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer

od Wang, Kyle, Heron, Dwight E, Flickinger, John C, Rwigema, Jean-Claude M, Ferris, Robert L, Kubicek, Gregory J, Ohr, James P, Quinn, Annette E, Ozhasoglu, Cihat, Branstetter, Barton F
Wydane 2012

Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer

od Rajagopalan, Malolan S, Heron, Dwight E, Wegner, Rodney E, Zeh, Herbert J, Bahary, Nathan, Krasinskas, Alyssa M, Lembersky, Barry, Brand, Randall, Moser, A James, Quinn, Annette E, Burton, Steven A
Wydane w Radiat Oncol (2013)

Long-Term Outcomes After Stereotactic Radiosurgery for Spine Metastases: Radiation Dose–Response for Late Toxicity

od Ling, Diane C., Flickinger, John C., Burton, Steven A., Heron, Dwight E., Quinn, Annette E., Bejjani, Ghassan K., Engh, Johnathan A., Gerszten, Peter C., Amankulor, Nduka M., Vargo, John A.
Wydane w Int J Radiat Oncol Biol Phys (2018)

Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

od Horne, Zachary D, Clump, David A, Vargo, John A, Shah, Samir, Beriwal, Sushil, Burton, Steven A, Quinn, Annette E, Schuchert, Matthew J, Landreneau, Rodney J, Christie, Neil A, Luketich, James D, Heron, Dwight E
Wydane 2014